{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:52:37Z","timestamp":1781704357233,"version":"3.54.5"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>Our objective was to evaluate the diagnostic utility of 2 new proliferation markers, cyclin D1 and minichromosome maintenance complex component 2 (MCM2), in comparison with p16, p53, and Ki67 in differentiating the spectrum of smooth muscle tumors. An institutional database search from 2009 to 2017 identified 10 cases of uterine leiomyoma with bizarre nuclei (LBN), 12 smooth muscle tumors of uncertain malignant potential, and 13 leiomyosarcomas (LMS). Ten resected leiomyomas (LM) were included as controls. Immunohistochemistry was performed on the befitting representative block from each case. Ki67 was &lt;10% in all LMs and LBNs, whereas &gt;10% in all LMSs. Although wild-type in majority of cases, p53 was overexpressed in 38% of LMSs. Cyclin D1 nuclear positivity in LMs, LBNs, and smooth muscle tumors of uncertain malignant potentials ranged from 0% to 65% of neoplastic cells with mostly weak to moderate staining intensity. Instead, cyclin D1 expression was &lt;5% in all LMSs. The ratio of MCM2 positivity exhibited a similar wide range (&lt;1%\u201380%) in LMs, LBNs, and smooth muscle tumors of uncertain malignant potentials but interestingly, 92% (12\/13) of LMSs were diffusely and strongly positive for MCM2 (&gt;80% cell positivity). Overall, for diagnosis of LMS, the sensitivity for diffuse intense MCM2 staining was higher (92%) compared with diffuse staining for p16 (77%); however, specificity of MCM2 and p16 was comparable (94% and 97%, respectively). Herein, we describe the immunohistochemical profile of 2 new proliferation markers, cyclin D1 and MCM2 in uterine smooth muscle tumors. A combination of diffuse strong MCM2 and p16 reactivity with increased Ki67 index can reliably distinguish LMSs from benign histologic mimics.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000616","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T08:24:52Z","timestamp":1559895892000},"page":"354-361","source":"Crossref","is-referenced-by-count":14,"title":["Combination of MCM2 With Ki67 and p16 Immunohistochemistry Can Distinguish Uterine Leiomyosarcomas"],"prefix":"10.1097","volume":"39","author":[{"given":"Kianoosh","family":"Keyhanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice M.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta","family":"Chernetsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harman","family":"Sekhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1002\/cncr.28900","article-title":"Molecular analyses of 6 different types of uterine smooth muscle tumors: emphasis in atypical leiomyoma","volume":"120","author":"Zhang","year":"2014","journal-title":"Cancer"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmt058","article-title":"Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations","volume":"20","author":"Segars","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0b013e3181574d1e","article-title":"The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors","volume":"32","author":"Atkins","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R5-20230824","first-page":"4092","article-title":"Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability","volume":"50","author":"Fletcher","year":"1990","journal-title":"Cancer Res"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/modpathol.2016.107","article-title":"Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors","volume":"29","author":"Liegl-Atzwanger","year":"2016","journal-title":"Mod Pathol"},{"key":"R7-20230824","first-page":"293","article-title":"Chromosomal abnormalities in leiomyosarcomas","volume":"142","author":"Sreekantaiah","year":"1993","journal-title":"Am J Pathol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/modpathol.2009.122","article-title":"A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors","volume":"22","author":"Lee","year":"2009","journal-title":"Mod Pathol"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/PAS.0b013e318287779c","article-title":"Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up","volume":"37","author":"Mills","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2005.09.055","article-title":"Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma","volume":"101","author":"Leiser","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ygyno.2011.01.022","article-title":"Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis","volume":"121","author":"D\u2019Angelo","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.humpath.2011.12.020","article-title":"Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma","volume":"43","author":"Cornejo","year":"2012","journal-title":"Hum Pathol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/PGP.0b013e318195da9f","article-title":"Fascin expression in uterine smooth muscle tumors","volume":"28","author":"Kefeli","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R14-20230824","first-page":"2795","article-title":"An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas","volume":"8","author":"Allen","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/cncr.11586","article-title":"Differential gene expression in leiomyosarcoma","volume":"98","author":"Skubitz","year":"2003","journal-title":"Cancer"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/modpathol.2017.185","article-title":"Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors","volume":"31","author":"Croce","year":"2018","journal-title":"Mod Pathol"},{"issue":"suppl 1","key":"R17-20230824","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1038\/modpathol.2015.139","article-title":"Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia","volume":"29","author":"Oliva","year":"2016","journal-title":"Mod Pathol"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2407-6-203","article-title":"Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer","volume":"6","author":"Yang","year":"2006","journal-title":"BMC Cancer"},{"issue":"pt 11","key":"R19-20230824","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1242\/jcs.114.11.2027","article-title":"DNA replication licensing and human cell proliferation","volume":"114","author":"Stoeber","year":"2001","journal-title":"J Cell Sci"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/bbrc.1997.6865","article-title":"Expression, nuclear localization and interactions of human MCM\/P1 proteins","volume":"236","author":"Tsuruga","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/modpathol.2016.231","article-title":"MCM2: an alternative to Ki-67 for measuring breast cancer cell proliferation","volume":"30","author":"Yousef","year":"2017","journal-title":"Mod Pathol"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/DAD.0000000000000114","article-title":"Immunohistochemical expression of MCM2 in nonmelanoma epithelial skin cancers","volume":"36","author":"Abdou","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2559.2006.02430.x","article-title":"Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid","volume":"48","author":"Cho Mar","year":"2006","journal-title":"Histopathology"},{"key":"R24-20230824","first-page":"3049","article-title":"Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer","volume":"29","author":"Guzinska-Ustymowicz","year":"2009","journal-title":"Anticancer Res"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/gcc.20018","article-title":"Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling","volume":"40","author":"Quade","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"R26-20230824","first-page":"115","article-title":"Apoptotic cell death and p53 expression in leiomyosarcoma of soft-tissue origin","volume":"44","author":"Yoshida","year":"2001","journal-title":"Yonago Acta Med"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1593\/tlo.09166","article-title":"Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors","volume":"3","author":"Cunha","year":"2010","journal-title":"Transl Oncol"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"pt 1","key":"R29-20230824","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST0380217","article-title":"Regulation of cyclin D1 gene expression","volume":"38","author":"Witzel","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"R30-20230824","first-page":"1001","article-title":"Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas","volume":"12","author":"Rao","year":"1999","journal-title":"Mod Pathol"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/molehr\/7.11.1085","article-title":"Comparative analysis of cyclin D1 and oestrogen receptor (alpha and beta) levels in human leiomyoma and adjacent myometrium","volume":"7","author":"Kovacs","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/PAS.0b013e31825fa931","article-title":"Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R33-20230824","first-page":"1037","article-title":"Tumor suppressor genes and related molecules in leiomyosarcoma","volume":"148","author":"Dei Tos","year":"1996","journal-title":"Am J Pathol"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2559.2007.02699.x","article-title":"Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential","volume":"50","author":"O\u2019Neill","year":"2007","journal-title":"Histopathology"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s005350170152","article-title":"Jejunal carcinoid tumor mimicking leiomyosarcoma: preoperative diagnosis by endoscopic biopsy","volume":"36","author":"Yoshida","year":"2001","journal-title":"J Gastroenterol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:49:31Z","timestamp":1692841771000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000616","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,5]]}}}